- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PIB-PET offers early proof of Alzheimer's disease onset
Groundbreaking research has confirmed that Pittsburgh Compound B binds to the beta-amyloid deposits in the brains of patients with Alzheimer's disease. The finding is a major step toward an early, definitive diagnosis of the memory-stealing condition.
Groundbreaking research has confirmed that Pittsburgh Compound B binds to the beta-amyloid deposits in the brains of patients with Alzheimer's disease. The finding is a major step toward an early, definitive diagnosis of the memory-stealing condition.
"As excited as researchers get, we are pretty excited," said senior author Dr. Steven T. DeKosky, director of the Alzheimer's Disease Research Center at the University of Pittsburgh.
DeKosky and colleagues studied a 63-year-old woman with a clinical diagnosis of AD who underwent PIB-PET imaging and brain autopsy upon her death 10 months later. The regions of her brain with the highest PIB levels before death correlated precisely with those with high beta-amyloid plaque concentration postmortem. An additional 27 brain autopsies confirmed the findings, which investigators reported in the March 12 online issue of Brain.
Mammography Study: Can Stand-Alone AI Enhance Detection of Interval Breast Cancer?
August 28th 2024Identifying over 23 percent of interval breast cancers with a 96 percent sensitivity in mammography interpretation, an emerging AI software also facilitated correct localization in over 75 percent of cases involving interval breast cancer, according to new research.
Can AI Facilitate Effective Triage for Supplemental Breast MRI After Negative Mammography Screening?
July 10th 2024The AISmartDensity software facilitated a cancer detection rate (CDR) with breast MRI that was nearly four times higher than the CDR previously reported in trials involving traditional breast density assessment.
